article thumbnail

Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

Systematic search conducted without language restrictions from December 1, 2019 to June 31, 2022 on PubMed, EMBASE, Web of Science, Cochrane library, ProQuest Coronavirus Research Database, COVID-19 Living Overview of the Evidence (L-OVE) subset of Episteminokos and the World Health Organization (WHO) Covid-19 databases.

article thumbnail

Diagnostic pathways, cardiac manifestations and outcomes in light chain amyloidosis: analysis of a US claims database

Open Heart

We qualitatively and quantitatively characterised the diagnostic pathway and the impact of delayed diagnosis on health outcomes among patients with AL amyloidosis. We stratified patients based on time from first cardiovascular (CV) manifestation onset to diagnosis.

article thumbnail

Impact of COVID-19 pandemic on rates of congenital heart disease procedures among children: prospective cohort analyses of 26 270 procedures in 17 860 children using CVD-COVID-UK consortium record linkage data

Open Heart

Methods and results We analysed 26 270 procedures from 17 860 children between 1 January 2018 and 31 March 2022 in England, linking them to primary/secondary care data. We compared procedure characteristics and outcomes between each pandemic period and the prepandemic period.

article thumbnail

Statement on long-term cardiovascular consequences of maternal hypertension: call for urgent action

Heart BMJ

The timely launch of the Women’s Health Strategy for England in 2022 focuses attention on the changing health and needs of women across their life. One in five women suffer from hypertension worldwide, and almost half of the mortality in women is caused by cardiovascular disease (CVD) (WHO).

article thumbnail

CareDx Launches Two Expanded Indications for AlloSure Testing Services

DAIC

Now, we have a well-validated, non-invasive tool to monitor organ rejection and injury, which has the potential to improve their quality of life and long-term outcomes. "We 2022 Feb;26(1):e14124. Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation.

article thumbnail

Winning the Battle Against Atherosclerosis: Practical, Proactive Solutions

Cardiometabolic Health Congress

Precision Medicine: Personalizing Prevention for Better Outcomes Precision medicine provides tools to customize prevention and treatment plans based on individual risk factors. Studies, such as those published in JACC (2022) , show that early identification can lead to targeted interventions, reducing long-term risk.

article thumbnail

Single-dose modified bloodless del Nido cardioplegia for minimally invasive cardiac surgery

Frontiers in Cardiovascular Medicine

We aimed to evaluate the efficacy of our modified bloodless del Nido cardioplegia in MICS compared to the histidine-tryptophan-ketoglutarate (HTK) solution.MethodsWe retrospectively reviewed 471 patients who underwent minimally invasive cardiac surgery (MICS) in our institution between January 2015 and September 2022.